MYCN amplification has been previously demonstrated to correlate with tumor progression and increased malignant potential in PCC.[35] Multivariate Cox regression analysis of overall survival demonstrated that the gene expression signatures of this specific cell type could predict patient prognosis based on MYCN amplification status (Figure 5F). The gene discussed is MYCN; the disease is adrenal gland pheochromocytoma.